Challenges and Controversies in Perioperative Immunotherapy in Early-Stage Non-small Cell Lung Cancer: An Optimistic Perspective

Immune checkpoint inhibitors have transformed the treatment landscape of non-small cell lung cancer (NSCLC), extending their role from metastatic to resectable disease. While neoadjuvant and adjuvant immunotherapies have each shown clinical value, recent evidence suggests that a perioperative strate...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Duk-ki Kim, Jeong Eun Lee
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	The Korean Academy of Tuberculosis and Respiratory Diseases 2026-04-01
Schriftenreihe:	Tuberculosis and Respiratory Diseases
Schlagworte:	non-small cell lung cancer perioperative immunotherapy neoadjuvant therapy adjuvant therapy pd-l1
Online-Zugang:	http://e-trd.org/upload/pdf/trd-2025-0111.pdf
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!